← Today’s ReceiptsSource pending
Public-record receiptD-CASource pending
Ro Khanna disclosed BUY $JNJ
Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.
Trade range
$15K – $50K
Filed
2025-12-08
Trade date
2025-11-07
Disclosure lag
31 days after trade
Why this receipt matters
A quick read before you share it.
These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.
1The disclosure is tracked with source status pending, so treat it as a record to verify rather than a finished source trail.
2The filing appeared 31 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $15K – $50K, which is the public reporting band rather than an exact profit or loss figure.
425 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Ro Khanna, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 35 lobbying filings and 1 federal contract record.
Source
source pending
Source: indexed congressional disclosure; official source link pending · filed 2025-12-08 · disclosed 31d after transaction
Market context
Johnson & Johnson
Sector: Healthcare
Vs SPY: 26.6%
Factual flags
- 35 lobbying filings linked to this ticker.
- 1 federal contract record linked to this ticker.
- 25 nearby same-ticker disclosures in the surrounding 30-day window.
- JNJ transaction date was 18d after a public lobbying filing by JOHNSON & JOHNSON SERVICES INC ($2,480,000); committee-sector context: Technology; this is timing context, not a finding of intent.
Member trail
Ro Khanna
U.S. House · CA-17
House Committee on Armed ServicesHouse Committee on Oversight and Government ReformHouse Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party
Ticker trail
$JNJ
Johnson & Johnson
Follow this tickerAlert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.